November 06, 2023
2 min watch
Save
VIDEO: IOL with bimatoprost-delivery platform shows promise for long-term IOP lowering
Issue: December 10, 2023
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Preeya K. Gupta, MD, discusses the potential of the SpyGlass Pharma IOL and bimatoprost delivery platform for lowering IOP long-term.
“A new product that is under investigation by SpyGlass is a new intraocular lens with a drug-delivery system that will deliver bimatoprost for 3 years in patients who require intraocular pressure control,” Gupta said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Gupta reports consulting for SpyGlass Pharma.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.